BioPharm International-12-16-2013

December 16, 2013

Clinical-stage biopharmaceutical company Ambrx leverages its site-specific bioconjugation technology through partnerships.

December 16, 2013

The little-known exception to the patent term extension law is potentially valuable but easy to miss.

December 16, 2013

Partnering with CDMOs can help bridge the innovation gap.

December 16, 2013

NPS Pharmaceuticals uses its expertise in development, regulatory compliance, and commercialization to bring to market products with orphan drug status.

December 16, 2013

The biopharmaceutical industry must consider new ways to manage innovation, including how product data are handled.

December 16, 2013

Caution should be taken when planning to crowdfund a biopharmaceutical startup.

December 16, 2013

Merck Serono fuels innovation with an integrated research, development, and manufacturing program and seed funding for startups.